ClinicalTrials.Veeva

Menu

LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia

C

China Medical University

Status

Begins enrollment in 4 months

Conditions

Hypertension
Diabetes
Dyslipidemia

Treatments

Other: LLM-Enabled Clinician-Patient Co-management

Study type

Interventional

Funder types

Other

Identifiers

NCT07350486
CMU-HyperMindRCT-2025

Details and patient eligibility

About

This study aims to evaluate the effectiveness of a large language model (LLM)-supported, community-based integrated management model in improving cardiometabolic multimorbidity control among adults with hypertension and coexisting diabetes or dyslipidemia. Adopting an interventional study design, eligible patients will be recruited to compare the disease control indicators between LLM-assisted management and conventional management, so as to verify the effectiveness and safety of the former.

Enrollment

6,000 estimated patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Participating communities must meet all of the following criteria:

  • Have a designated community physician responsible for primary care who is capable of using a smartphone with stable internet access for clinical communication and LLM-assisted management;
  • No plan for administrative merger or restructuring within the next three years;
  • Located at least 2 kilometers away from adjacent participating communities (to minimize contamination between clusters).

Eligible participants must fulfill all of the following conditions:

  • Aged 40 years or older;
  • Uncontrolled hypertension, defined as systolic blood pressure (SBP) ≥140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg;
  • Coexisting diabetes (HbA1c ≥ 7.0%) or coexisting dyslipidemia (LDL-C ≥ 3.4 mmol/L[130 mg/dL]);
  • Able to use a smartphone independently or with assistance from family members;
  • Has resided in the participating community for at least 6 months;
  • Has no plan to relocate in the next 3 years;
  • Enrolled in basic medical insurance for urban and rural residents, employee medical insurance, or the New Rural Cooperative Medical Scheme;
  • Not currently pregnant or planning pregnancy during the study period;
  • Free from malignant tumors and deemed to have a life expectancy of at least 3 years, as judged by study physicians;
  • Willing and able to provide written informed consent.

Exclusion Criteria:No specific exclusion criteria.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

6,000 participants in 2 patient groups

LLM-Enabled Intervention Group
Active Comparator group
Description:
LLM-enabled community physicians delivered integrated, guideline-based management
Treatment:
Other: LLM-Enabled Clinician-Patient Co-management
Usual Care Control Group
No Intervention group
Description:
Community physicians provided routine care according to local primary health service standards

Trial contacts and locations

1

Loading...

Central trial contact

Xiaofan Guo, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems